LSP V Cooperatieve U.A. 13D/13G Filings for Eloxx Pharmaceuticals, Inc. (ELOX)

LSP V Cooperatieve U.A. 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-03
4:16 pm
Unchanged
3021-12-3113DEloxx Pharmaceuticals, Inc.
ELOX
LSP V Cooperatieve U.A.73,842
3.400%
0
(Unchanged)
Filing
2020-03-13
4:15 pm
Purchase
2020-03-0613DEloxx Pharmaceuticals, Inc.
ELOX
LSP V Cooperatieve U.A.73,842
7.400%
7,500increase
(+11.31%)
Filing